|
|
|
|
| LEADER |
00000cam a2200000Mu 4500 |
| 001 |
EBOOKCENTRAL_on1347023638 |
| 003 |
OCoLC |
| 005 |
20240329122006.0 |
| 006 |
m o d |
| 007 |
cr cnu|||||||| |
| 008 |
230209s2015 xx o ||| 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|c EBLCP
|d OCLCQ
|d OCLCO
|d OCLCQ
|d EBLCP
|d OCLCQ
|d OCLCL
|
| 020 |
|
|
|a 9781118889947
|
| 020 |
|
|
|a 1118889940
|
| 035 |
|
|
|a (OCoLC)1347023638
|
| 082 |
0 |
4 |
|a 616.1/061
|q OCoLC
|2 23/eng/20230216
|
| 049 |
|
|
|a UAMI
|
| 100 |
1 |
|
|a Li, Y. Robert.
|
| 245 |
1 |
0 |
|a Cardiovascular Diseases
|h [electronic resource] :
|b From Molecular Pharmacology to Evidence-Based Therapeutics.
|
| 260 |
|
|
|a Newark :
|b John Wiley & Sons, Incorporated,
|c 2015.
|
| 300 |
|
|
|a 1 online resource (504 p.).
|
| 490 |
1 |
|
|a New York Academy of Sciences Ser.
|
| 500 |
|
|
|a Description based upon print version of record.
|
| 505 |
0 |
|
|a Intro -- Title Page -- Copyright Page -- Contents -- Preface -- List of Abbreviations -- Unit I General Introduction -- Chapter 1 Introduction to Cardiovascular Diseases -- 1.1 Overview -- 1.2 Definition of Cardiovascular Diseases -- 1.3 Classification of Cardiovascular Diseases -- 1.3.1 Classification Based on Anatomical Location -- 1.3.2 Classification Based on the Involvement of Atherosclerosis -- 1.3.3 Total Cardiovascular Diseases and ICD-10 Classification -- 1.4 Prevalence, Incidence, and Trend of Cardiovascular Diseases -- 1.4.1 NCDs and Cardiovascular Diseases: The Global Status
|
| 505 |
8 |
|
|a 1.4.2 The Status of Cardiovascular Diseases in the United States -- 1.4.3 The Status of Cardiovascular Diseases in China -- 1.5 Risk Factors of Cardiovascular Diseases -- 1.5.1 Classification of Cardiovascular Disease Risk Factors -- 1.5.2 Major Cardiovascular Disease Risk Factors and Their Impact -- 1.6 Prevention and Control of Cardiovascular Diseases -- 1.6.1 The UN High-Level Meeting and Tackling Cardiovascular Diseases at the Global Level -- 1.6.2 The World Heart Federation Call to Action to Prevent and Control Cardiovascular Diseases
|
| 505 |
8 |
|
|a 1.6.3 The AHA 2010 Health Impact Goal, 2020 Health Impact Goal, and Ideal Cardiovascular Health -- 1.6.4 US DHSS "Million Hearts" Initiative -- 1.7 Cardiovascular Risk Prediction and Evidence-based Treatments -- 1.7.1 Cardiovascular Risk Prediction -- 1.7.2 Evidence-Based Treatments -- 1.8 Summary of Chapter Key Points -- 1.9 Self-Assessment Questions -- References -- Chapter 2 Introduction to Principles of Pharmacology -- 2.1 Overview -- 2.2 Definitions and History -- 2.2.1 What Is Pharmacology? -- 2.2.2 Definitions of Related Terms -- 2.2.3 A Brief History of Pharmacology
|
| 505 |
8 |
|
|a 2.3 Pharmacological Paradigm: the Central Dogma in Pharmacology -- 2.3.1 Drug Names, Sources, Preparations, and Administration -- 2.3.2 Pharmacokinetics -- 2.3.3 Pharmacodynamics -- 2.3.4 Drug Toxicity -- 2.3.5 Pharmacogenetics and Pharmacogenomics -- 2.4 Principles of Drug Discovery, Development, and Regulation -- 2.4.1 Definitions -- 2.4.2 The Paradigm of Drug Creation and Survival -- 2.4.3 The FDA Drug Review and Approval Process -- 2.5 Pharmacology Subspecialties -- 2.6 Introduction to Cardiovascular Pharmacology -- 2.6.1 Definition and Scope -- 2.6.2 New Developments and Challenges
|
| 505 |
8 |
|
|a 2.6.3 Systems Pharmacology in the Management of Cardiovascular Diseases -- 2.6.4 Polypill for the Management of Cardiovascular Diseases -- 2.6.5 Protein Therapeutics of Cardiovascular Diseases -- 2.6.6 Gene Therapy of Cardiovascular Diseases -- 2.6.7 Stem Cell Therapy of Cardiovascular Diseases -- 2.7 Summary of Chapter Key Points -- 2.8 Self-Assessment Questions -- References -- Unit II Dyslipidemias -- Chapter 3 Overview of Dyslipidemias and Drug Therapy -- 3.1 Introduction -- 3.2 Lipoprotein Metabolism -- 3.2.1 Definition, Structure, and Classification of Lipoproteins
|
| 500 |
|
|
|a 3.2.2 Metabolic Pathways of Lipoproteins and Drug Therapy
|
| 590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
| 655 |
|
0 |
|a Electronic books.
|
| 758 |
|
|
|i has work:
|a Cardiovascular diseases (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCGqYVfHf397c7FbWXrq4v3
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
| 776 |
0 |
8 |
|i Print version:
|a Li, Y. Robert
|t Cardiovascular Diseases
|d Newark : John Wiley & Sons, Incorporated,c2015
|z 9780470915370
|
| 830 |
|
0 |
|a New York Academy of Sciences Ser.
|
| 856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=7104191
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL7104191
|
| 994 |
|
|
|a 92
|b IZTAP
|
